Showing 1,459 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental HIV treatments

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Editor's pick
News Medical Net
15 October 2013
Pharmaceutical industry

TAC debunks pharma’s myths around patent law reform

Editor's pick
Fix the Patent Laws
14 October 2013
New & experimental hepatitis C treatment

Idenix Shares Fall as J&J Buys Rival Hepatitis C Therapy

Editor's pick
Bloomberg
8 October 2013
New & experimental hepatitis C treatment

Investigational interferon-free regimen demonstrates undetectable hepatitis C virus in all patients reaching end of treatment in ongoing Phase II trial

Editor's pick
Boehringer-Ingelheim press release
8 October 2013
New & experimental hepatitis C treatment

Janssen Acquires Investigational NS5A Inhibitor for the Treatment of Hepatitis C from GlaxoSmithKline

Editor's pick
Janssen press release
8 October 2013
PrEP

PATH Evaluates Janssen’s Rilpivirine as HIV Infection Prophylactic

Editor's pick
Genetic Engineering & Biotechnology News
25 September 2013
Pharmaceutical industry

U.S. Government Shutdown Could Postpone FDA Advisory Panels

Editor's pick
The Street
25 September 2013
Pharmaceutical industry

Seven Ways to Speed up the HIV Treatment Pipeline

Editor's pick
Positive Lite
24 September 2013
New & experimental HIV treatments

Will Germany Squelch Gilead Hopes For Its Stribild AIDS Drug?

Editor's pick
Pharmalot
19 September 2013
TB treatment

2013 Tuberculosis Medicines Technology and Market Landscape

Editor's pick
UNITAID
17 September 2013
Global health initiatives

UNITAID wooing India to become contributing member

Editor's pick
PharmBiz
13 September 2013
Hepatitis B

Medivir and Daewoong pull plug on hepatitis B drug

Editor's pick
PharmaTimes
6 September 2013
Bad science & bogus treatments

Cameroonians ‘Dying’ for Fake Drugs

Editor's pick
Inter Press Service
5 September 2013
New & experimental hepatitis C treatment

Merck demand triggers expanding patent war with Gilead over sofosbuvir

Editor's pick
FierceBiotech
2 September 2013
Pharmaceutical industry

ViiV goes for gold: US premium pricing may threaten dolutegravir use in Europe

Editor's pick
HIV i-Base
19 August 2013
Access to healthcare

Medicines Patent Pool Is 'Taken Seriously' Now: Perry Explains

Editor's pick
Pharmalot
15 August 2013
New & experimental HIV treatments

ViiV's newly minted HIV fighter Tivicay to cost $14K per year

Editor's pick
Fierce Pharma
14 August 2013
New & experimental HIV treatments

FDA approves new drug to treat HIV infection

Editor's pick
FDA
13 August 2013
Access to healthcare

HIV Survivors Seek Drug Advances as FDA Eases Approvals

Editor's pick
Bloomberg
12 August 2013
Access to healthcare

Roche and the Medicines Patent Pool Sign Agreement to Increase Access to Medicines to Treat CMV infection in HIV-patients, a major cause of Blindness

Editor's pick
Roche press release
5 August 2013
Pharmaceutical industry

China Revokes Viread Patent; Pricing Was at Issue

Editor's pick
Bioworld.com
5 August 2013
Pharmaceutical industry

Gilead profit up 8.6% on sales growth of HIV drugs - MarketWatch

Editor's pick
Google Alerts HIV
26 July 2013
Activism & civil society

EATG statement: Big pharma mobilising patients in battle over drugs trials data

Editor's pick
EATG
22 July 2013
New & experimental hepatitis C treatment

How to Save $200 Billion and Cure Hepatitis C

Editor's pick
Xconomy
22 July 2013